drugset

drugset / Trial / NCT00547287

Studying the Preference of Tadalafil to Sildenafil in Men With Problems Getting an Erection Across Nations

NCT00547287 ↗

Phase 3 Completed 2760 enrolled Eli Lilly and Company ICOS Corporation · collab

CrossoverOpen-labelTreatment

Summary

Study to determine if men from around the world prefer sildenafil to tadalafil.

Timeline

Start: 2002-11
Primary completion: —
Completion: 2004-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Sildenafil	Unknown	—	—
Comparator	Tadalafil	Small molecule	20 mg	Oral

Indications